About Remedy Pharmaceuticals
Remedy Pharmaceuticals is a company based in New York (United States) founded in 2004 was acquired by Biogen in May 2017.. Remedy Pharmaceuticals has raised $22.76 million across 7 funding rounds from investors including Biogen, The Vertical Group and Broadview Ventures. The company has 6 employees as of December 31, 2022. Remedy Pharmaceuticals offers products and services including CIRARA. Remedy Pharmaceuticals operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter New York, United States
- Employees 6 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Remedy Pharmaceuticals Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Remedy Pharmaceuticals
Remedy Pharmaceuticals offers a comprehensive portfolio of products and services, including CIRARA. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Inhibits SUR1-TRPM4 channels to prevent cerebral edema in stroke patients.
Unlock access to complete
Unlock access to complete
Funding Insights of Remedy Pharmaceuticals
Remedy Pharmaceuticals has successfully raised a total of $22.76M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $3.7 million completed in November 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series D — $3.7M
-
First Round
First Round
(08 Sep 2010)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2016 | Amount | Series D - Remedy Pharmaceuticals | Valuation |
investors |
|
| Dec, 2015 | Amount | Series D - Remedy Pharmaceuticals | Valuation | The Vertical Group |
|
| Feb, 2014 | Amount | Series C - Remedy Pharmaceuticals | Valuation | Broadview Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Remedy Pharmaceuticals
Remedy Pharmaceuticals has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Biogen, The Vertical Group and Broadview Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in early and late-stage US companies are made.
|
Founded Year | Domain | Location | |
|
Seed-stage life sciences investments are made in the US.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Remedy Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Remedy Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Remedy Pharmaceuticals Comparisons
Competitors of Remedy Pharmaceuticals
Remedy Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Remedy Pharmaceuticals
Frequently Asked Questions about Remedy Pharmaceuticals
When was Remedy Pharmaceuticals founded?
Remedy Pharmaceuticals was founded in 2004 and raised its 1st funding round 6 years after it was founded.
Where is Remedy Pharmaceuticals located?
Remedy Pharmaceuticals is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Remedy Pharmaceuticals a funded company?
Remedy Pharmaceuticals is a funded company, having raised a total of $22.76M across 7 funding rounds to date. The company's 1st funding round was a Series C of $1.02M, raised on Sep 08, 2010.
How many employees does Remedy Pharmaceuticals have?
As of Dec 31, 2022, the latest employee count at Remedy Pharmaceuticals is 6.
What does Remedy Pharmaceuticals do?
Remedy Pharmaceuticals was founded in 2004 in New York, United States, within the pharmaceuticals sector. Operations center on the development and commercialization of Cirara, a patented intravenous inhibitor targeting channels upregulated in ischemic and traumatic injuries. Conditions addressed include ischemic and hemorrhagic stroke, traumatic brain injury, spinal cord injury, and other ischemic events. Delivery occurs bedside or in ambulances via proprietary MPD technology for targeted dosing.
Who are the top competitors of Remedy Pharmaceuticals?
Remedy Pharmaceuticals's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Remedy Pharmaceuticals offer?
Remedy Pharmaceuticals offers CIRARA.
Who are Remedy Pharmaceuticals's investors?
Remedy Pharmaceuticals has 4 investors. Key investors include Biogen, The Vertical Group, Broadview Ventures, and Green Circle Capital Partners.